Matthew C. Abernethy
2020
Compensation breakdown
| Bonus | $190,820 |
|---|---|
| Option Awards | $2,999,869 |
| Salary | $545,200 |
| Stock Awards | $2,500,266 |
| Other | $45,021 |
| Total | $6,281,176 |
Abernethy received $3M in option awards, accounting for 48% of the total pay in 2020.
Abernethy also received $190.8K in bonus, $545.2K in salary, $2.5M in stock awards and $45K in other compensation.
Rankings
In 2020, Matthew C. Abernethy's compensation ranked 1,642nd out of 13,090 executives tracked by ExecPay. In other words, Abernethy earned more than 87.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,642 out of 13,090 | 88th |
Division Manufacturing | 620 out of 5,621 | 89th |
Major group Chemicals And Allied Products | 223 out of 2,254 | 90th |
Industry group Drugs | 186 out of 1,954 | 91st |
Industry Biological Products, Except Diagnostic Substances | 56 out of 411 | 86th |
Pay ratio
| Matthew C. Abernethy's Pay | $6,281,176 |
|---|---|
| Median Employee's Pay | $241,848 |
| Pay Ratio | 26to 1 |
In 2020, the annual total compensation of Matthew C. Abernethy was $6,281,176.
The annual total compensation of the median employee at Neurocrine Biosciences was $241,848.
The ratio of Matthew C. Abernethy's pay to the pay of median employee was therefore 26 to one.
Abernethy's colleagues
We found four more compensation records of executives who worked with Matthew C. Abernethy at Neurocrine Biosciences in 2020.
News
April 7, 2022
April 9, 2021
April 9, 2020
April 17, 2019